A Study With NKT3447 for Adults With Advanced/Metastatic Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Triple Negative Breast Cancer
Related studies linked through entity extraction aliases.
LAG3 Expression in Triple Negative Breast Cancer
- Status
- RECRUITING
- Phase
- NA
A Study of Pembrolizumab and Cryoablation in People With Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Breast/Cyclosporin A/TNBC (Triple Negative Breast Cancer)
- Status
- WITHDRAWN
- Phase
- EARLY_PHASE1
PET Dynamics to Response-Adapted Neoadjuvant Therapy in TNBC
- Status
- RECRUITING
- Phase
- PHASE2
Sacituzumab Govitecan and Zimberelimab w/SRS in the Management of Metastatic Triple Negative Breast Cancer With Brain Metastases
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Efficacy and Safety of PD-L1 Monoclonal Antibody Combined With Metronomic VEX in Advanced Triple-negative Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Early Detection of Triple Negative Breast Cancer Relapse (CUPCAKE)
- Status
- RECRUITING
- Phase
- NA
Neoadjuvant Chemotherapy With or Without GnRH Agonist for Premenopausal Triple-negative Early Breast Cancer Patients
- Status
- RECRUITING
- Phase
- PHASE2
ARX788 for Treating Patients With HER2-low Locally Advanced Unresectable or Metastatic Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Neoadjuvant Therapy and Contrast-enhanced Mammography for Early Stage Breast Cancer
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Study of Cadonilimab (AK104) Plus Eribulin vs. Eribulin Monotherapy for Recurrent or Metastatic Triple-negative Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Prospective Evaluation of AI R&D Tool for Patient Stratification - MoA Evaluation in Triple Negative Breast Cancer (PEAR-MET)
- Status
- RECRUITING
- Phase
- N/A
Tiragolumab, Atezolizumab and Chemotherapy in Triple Negative Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
PRO1107 in Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
A Study of Tetrathiomolybdate (TM) Plus Capecitabine
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Predicting BReast cAncer Response to neoadjuVant Therapy by ctDNA Assessment
- Status
- RECRUITING
- Phase
- N/A
Targeting MDMD and PD1 in Tumors With Tertiary Lymphoid Structures
- Status
- WITHDRAWN
- Phase
- PHASE2